Author Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma (Nature Medicine, (2006), 12, 8, (939-944), 10.1038/nm1447);Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

Nature Medicine

Volumn 12, Issue 8, 2006, Pages 939-944

  Thaker, Premal H ^a   Han, Liz Y ^a   Kamat, Aparna A ^a   Arevalo, Jesusa M ^b   Takahashi, Rie ^b   Lu, Chunhua ^a   Jennings, Nicholas B ^a   Armaiz Pena, Guillermo ^a   Bankson, James A ^a   Ravoori, Murali ^a   Merritt, William M ^a   Lin, Yvonne G ^a   Mangala, Lingegowda S ^a   Kim, Tae Jin ^a   Coleman, Robert L ^a   Landen, Charles N ^a   Li, Yang ^a   Felix, Edward ^a   Sanguino, Angela M ^a   Newman, Robert A ^a   Lloyd, Mary ^a   Gershenson, David M ^a   Kundra, Vikas ^a   Lopez Berestein, Gabriel ^a   Lutgendorf, Susan K ^c   Cole, Steven W ^b   Sood, Anil K ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c E11 SSH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GELATINASE A; GELATINASE B; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; ENDOCRINE FUNCTION; FEMALE; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; STRESS; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME;

ANIMALIA;

EID: 33746851955     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/s41591-021-01566-5     Document Type: Erratum

References (30)

1. Antoni, M.H. et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat. Rev. Cancer 6, 240-248 (2006).
2. Justice, A. Review of the effects of stress on cancer in laboratory animals: importance of time of stress application and type of tumor. Psychol. Bull. 98, 108-138 (1985).
3. Ben-Eliyahu, S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav. Immun. 17 (Suppl.), S27-S36 (2003).
4. Reiche, E.M., Nunes, S.O. & Morimoto, H.K. Stress, depression, the immune system, and cancer. Lancet Oncol. 5, 617-625 (2004).
5. McEwen, B. Seminars in Medicine of the Beth Israel Deaconness Medical Center: protective and damaging effects of stress mediators. N. Engl. J. Med. 338, 171-179 (1998).
6. Lutgendorf, S.K. et al. Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer 95, 808-815 (2002).
7. Lutgendorf, S.K. et al. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin. Cancer Res. 9, 4514-4521 (2003).
8. Thaker, P.H. et al. Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors. Clin. Cancer Res. 11, 4923-4933 (2005).
9. Paredes, A. et al. Stress promotes development of ovarian cysts in rats: the possible role of sympathetic nerve activation. Endocrine 8, 309-315 (1998).
10. Landen, C.N. et al. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res. 65, 6910-6918 (2005).
11. Langley, R.R. et al. Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis. Cancer Res. 63, 2971-2976 (2003).
12. Glaser, R. & Kiecolt-Glaser, J.K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 5, 243-251 (2005).
13. Lutgendorf, S. et al. Social support, psychological distress and natural killer cell activity in ovarian cancer. J. Clin. Oncol. 23, 7105-7113 (2005).
14. Chrousos, G.P. & Gold, P.W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. J. Am. Med. Assoc. 267, 1244-1252 (1992).
15. Basu, S. et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat. Med. 7, 569-574 (2001).
16. Teunis, M.A. et al. Reduced tumor growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system. FASEB J. 16, 1465-1467 (2002).
17. Seeman, T.E., Berkman, L.F., Blazer, D. & Rowe, J.W. Social ties and support and neuroendocrine function: the McArthur studies of successful aging. Ann. Behav. Med. 16, 95-106 (1994).
18. Turner-Cobb, J.M., Sephton, S.E., Koopman, C., Blake-Mortimer, J. & Spiegel, D. Social support and salivary cortisol in women with metastatic breast cancer. Psychosom. Med. 62, 337-345 (2000).
19. Antoni, M.H. et al. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Ann. Behav. Med. 22, 29-37 (2000).
20. Costanzo, E.S. et al. Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer 104, 305-313 (2005).
21. Sheridan, J.F. et al. Restraint stress differentially affects anti-viral cellular and humoral immune responses in mice. J. Neuroimmunol. 31, 245-255 (1991).
22. Aarons, R.D. & Molinoff, P.B. Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol. J. Pharmacol. Exp. Ther. 221, 439-443 (1982).
23. Exton, M.S. et al. Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and beta-adrenoceptors. J. Neuroimmunol. 131, 21-30 (2002).
24. Halder, J. et al. Focal adhesion kinase targeting for therapy of ovarian carcinoma using in vivo siRNA delivery in neutral liposomes. Clin. Cancer Res. (in the press).
25. Xu, L. et al. Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. Int. J. Oncol. 16, 445-454 (2000).
26. Reinmuth, N. et al. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J. 15, 1239-1241 (2001).
27. Passaniti, A. et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519-528 (1992).
28. Radinsky, R. et al. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res. 53, 937-943 (1993).
29. Hu, L. et al. Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model. Clin. Cancer Res. 11, 6966-6971 (2005).
30. Daldrup, H. et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am. J. Roentgenol. 171, 941-949 (1998).